nach oben

Erschienen in:

2015 | OriginalPaper | Buchkapitel

28. Grundlagen der gastrointestinalen Tumorerkrankungen

verfasst von : Moritz Schmelzle, PD Dr. med., Sven Jonas, Prof. Dr. med., Dirk Strumberg, Prof. Dr. med., Astrid Kaufmann, Dr. med., Stefan Aretz, Prof. Dr. med., Uta-Carolin Pietsch, Dr. med., Udo X. Kaisers, Prof. Dr. med., Katharina Monz, Dr. med., Karl-Axel Hartmann, Prof. Dr. med., Jutta Hübner, PD Dr. med., Florian Lordick, Prof. Dr. med., Martin Raida, Dr. med., Andreas Winter, Dr. med., Iris Burkholder, Prof. Dr. rer. nat., Lutz Edler, Dr. rer. nat.

Erschienen in: Viszeralmedizin

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Autoren

Viszeralchirurgie: M. Schmelzle, S. Jonas

Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13(1):11–26PubMed

Banerjee S, Kaye S (2011) PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond. Curr Oncol Rep 13(6):442–449PubMed

Baselga J, Swain SM (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9(7):463–475PubMed

Bradish JR, Montironi R, Lopez-Beltran A, Post KM, MacLennan GT, Cheng L (2013) Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations. Future Oncol 9(2):245–253PubMed

Brosh RM Jr (2013) DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer 13(8):542–558PubMed

Capaccione KM, Pine SR (2013) The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 34(7):1420–1430PubMedCentralPubMed

Chikamori K, Grozav AG, Kozuki T, Grabowski D, Ganapathi R, Ganapathi MK (2010) DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy. Curr Cancer Drug Targets 10(7):758–771PubMed

De P, Miskimins K, Dey N, Leyland-Jones B (2013) Promise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: old targets new hope. Cancer Treat Rev 39(5):403–412PubMed

Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE (2013) Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 73(6):1649–1657PubMed

Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10(8):561–574PubMed

Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13(4):246–257PubMed

Hilgart JS, Coles B, Iredale R (2012) Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2:CD003721PubMed

Huang Y, Goel S, Duda DG, Fukumura D, Jain RK (2013) Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res 73(10):2943–2948PubMedCentralPubMed

Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9(3):182–194PubMedCentralPubMed

Kershaw MH, Westwood JA, Darcy PK (2013) Gene-engineered T cells for cancer therapy. Nat Rev Cancer 13(8):525–541PubMed

Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M (2012) microRNAs in cancer management. Lancet Oncol 13(6):e249–258PubMed

Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12(12):860–875PubMed

Lens SM, Voest EE, Medema RH (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 10(12):825–841PubMed

di Magliano MP, Logsdon CD (2013) Roles for KRAS in pancreatic tumor development and progression. Gastroenterology 144(6):1220–1229PubMedCentralPubMed

Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11(8):558–572PubMed

Ng JM, Curran T (2011) The Hedgehog‘s tale: developing strategies for targeting cancer. Nat Rev Cancer 11(7):493–501PubMedCentralPubMed

Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12(4):265–277PubMedCentralPubMed

Sansone P, Bromberg J (2012) Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 30(9):1005–1014PubMedCentralPubMed

Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278–287PubMed

Sun X, Han L, Seth P, Bian S, Li L, Csizmadia E, Junger WG, Schmelzle M, Usheva A, Tapper EB, Baffy G, Sukhatme VP, Wu Y, Robson SC (2013) Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice. Hepatology 57(1):205–216PubMedCentralPubMed

Thelen A, Scholz A, Benckert C, von Marschall Z, Schröder M, Wiedenmann B, Neuhaus P, Rosewicz S, Jonas S (2008) VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 122(11):2471–2481PubMed

Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10(8):537–549PubMed

Wade M, Li YC, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13(2):83–96PubMedCentralPubMed

Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537–549PubMed

Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13(4):343–351PubMed

Calle EE et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638PubMed

De Wijkerslooth TR et al (2012) Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 107:1570PubMed

Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoiable risks of cancer in the United States today. J Nath Cancer Inst 66:1191–1208

Ewald N, Toepler M, Akinci A, Koer HU, Bretzel RG, Hardt PD (2005) Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data. Z Gastroenterol 43(12):1313–1317PubMed

Greenwald P, Weed DL (1995) Cancer prevention and control, cancer causes and control Harvard Report on Cancer Prevention. Causes of Human Cancer, Bd. 1. Marcel Dekker Inc, USA, S S55–S58

Higginson J, Muir CS (1979) Environmental carcinogenesis: misconceptions and limitations to cancer control. J Natl Cancer Inst 63:1291–1298PubMed

- (2002) Weight control and physical activity Bd. 6. International Agency for Reseach on Cancer, Lyon, France

Imperiale TF et al (2014) Multitargeted stool DNA testing for colorectal-cancer screening. N Engl J Med 370(14):1287–1297PubMed

Naumann M, Oromek GM, Hanisch E, Rösch W, Mössner J, Caspary W, Stein J (2005) Prospektive Evaluierung von Tumor M2-PK im Stuhl als neuen Screeningmarker für kolorektale Neoplasien – Ergebnisse einer multizentrischen prospektiven Studie. Z Gastroenterol (43):P507 doi:10.1055/s-2005-920298

Schmiegel W et al (2008) S3-Leitlinie „Kolorektales Karzinom“. Z Gastroenterol (46):1–73

Sharma P (2009) Barrett’s Esophagus. N Engl J Med 361:2548–2556PubMed

Strumberg D, Boeing H, Scheulen ME, Förster H, Seeber S (2004) Nutrition, lifestyle and risk of cancer: strategies for cancer prevention. Dtsch Med Wochenschr 129:1877–1882PubMed

WHO (2003) posting date. www.who.int/hpr/NPH/docs/who_fao_expert_report.pdf

Wynder EL, Gori GB (1977) Contribution of the environment to cancer incidence: an epidemiologic exercise. J Natl Cancer Inst 58:825–832PubMed

Aretz S (2010) Differentialdiagnostik und Früherkennung hereditärer gastrointestnaler Polyposis-Syndrome. Deutsches Ärzteblatt 107(10):163–173

Aretz S (2014) Erbliche Tumorsyndrome. In: Moog U, Rieß O (Hrsg) Medizinische Genetik für die Praxis. Diagnostik, Beratung, Fallbeispiele. Thieme, Stuttgart, S 151–182

Aretz S, Propping P, Noethen M (2006) Indikationen zur molekulargenetischen Diagnostik bei erblichen Krankheiten. Deutsches Ärzteblatt 103:A550–A558

Bartsch DK, Gress TM, Langer P (2012) Familial pancreatic cancer – current knowledge. Nat Rev Gastroenterol Hepatol 9:445–453PubMed

Galiatsatos P, Foulkes WD (2006) Familial adenomatous polyposis. Am J Gastroenterol 101:385–398PubMed

Jass JR (2008) Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract 204:431–447PubMed

Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100(10):1043–1049 (Sep)PubMed

Lynch HAT et al (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1–18PubMedCentralPubMed

Oliveira C, Seruca R, Carneiro F (2009) Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 23:147–157PubMed

Rosty C, Parry S, Young JP (2011) Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int 157073 doi:10.4061/2011/157073

Sampson JR, Jones N (2009) MUTYH-associated polyposis. Best Pract Res Clin Gastroenterol 23:209–218PubMed

Schulmann K, Pox C, Tannapfel A, Schmiegel W (2007) The patient with multiple intestinal polyps. Best Pract Res Clin Gastroenterol 21:409–426PubMed

Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124:380–391PubMed

Spier I, Holzapfel S, Steinke V, Aretz S (2013) Genetik gastrointestinaler Tumoren – Welche Folgen haben Keimbahnmutationen? Gastroenterologe 8:303–315

Steinke V, Vogt S, Aretz S (2010) Klinik und Genetik des familiären Dickdarmkrebses. Medizinische Genetik 22:265–281

Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P (2013) Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome. Dtsch Arztebl Int 110(3):32–38PubMedCentralPubMed

Zbuk KM, Eng C (2007) Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 4:492–502PubMed

Zerres K (2003) Humangenetische Beratung. Deutsches Ärzteblatt 100:A2720–2727

Bundgaard-Nielsen M, Secher NH, Kehlet H (2009) ‚Liberal‘ vs. ‚restrictive‘ perioperative fluid therapy – a critical assessment of evidence. Acta Anaesthesiol Scand 53:1324–1328PubMed

García-Miguel FJ, Serrano-Aguilar PG, López-Bastida J (2003) Preoperative assessment. Lancet 362:1749–1757PubMed

Jambor C, Spannagl M, Zwissler B (2009) Perioperatives Management von Patienten mit Koronarstents bei nichtherzchirurgischen Eingriffen. Anästhesist 58:971–985

Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S, Fort I, Juanatey JR, Gorenek B, Heyndrckx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck-Brentano C, Authors Task Force Members (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management oft he European Society of Anaesthesiology (ESA). Eur J Anaestesiol 31:517–573

Lentschener C, Ozier Y (2002) Anesthesia for elective liver resection – some points should be revisited. Eur J Anaesthesiol 19:780–788PubMed

Mutlak H, Czerner S, Winter H, Zwissler B, Lackermeier P (2010) Präoperative Evaluierung und Risikoeinschätzung in der Thoraxchirurgie. Anästhesist 59:918–928

Poldermans D, Bax JJ, Boersma E, deHert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OFM, Sicari R, van den Berghe G, Vermassen F (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30:2769–2812PubMed

Priebe HJ (2011) Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. Br J Anaesth 107:83–96PubMed

Smetana GW, Lawrence VA, Cornell JE, American College of Physicians (2006) Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 144:581–595PubMed

Smith I, Kranke P, Murat I, Smith A, O’Sullivan G, Soreide E, Spies C, in’t Vold B, European Society of Anaesthesiology (2011) Preoperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 28:556–569PubMed

Stuart PC (2006) The evidence base behind modern fasting guidelines. Best Pract Res Clin Anaesthesiol 20:457–469PubMed

Theilmeier C, Coldewey SM (2009) Perioperatives Risiko. In: Kochs E, Adams HA, Spiess C (Hrsg) Anästhesiologie, 2. Aufl. Thieme, Stuttgart, S 570–579

Waurick K, Riess H, Van Aken H, Kessler P, Gogarten W, Volk T (2014) S-1-Leitlinie Rückenmarknahe Regionalanästhesien und Thrombembolieprophylaxe/antithrombotische Medikation. Anästh Intensivmed 55:464–492

Weiß G, Jacob M (2008) Präoperative Nüchternheit. Anästhesist 57:857–872

Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238(4):508–518 (discussion 518–519)PubMedCentralPubMed

Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Française de Chirurgie (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–535PubMedCentralPubMed

am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT (2012) Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg 255(1):79–85

Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P (2013) Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of the immunopathological classification. Int J Hepatol 2013:268625PubMedCentralPubMed

Bickenbach KA, Denton B, Gonen M, Brennan MF, Coit DG, Strong VE (2013) Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol 20(3):780–787PubMed

van Bree SH, Vlug MS, Bemelman WA, Hollmann MW, Ubbink DT, Zwinderman AH, de Jonge WJ, Snoek SA, Bolhuis K, van der Zanden E, The FO, Bennink RJ, Boeckxstaens GE (2011) Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology 141(3):872–880PubMed

Cucchetti A, Piscaglia F, Cescon M, Colecchia A, Ercolani G, Bolondi L, Pinna AD (2013) Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol 59(2):300–307PubMed

van Dam RM, Wong-Lun-Hing EM, van Breukelen GJ, Stoot JH, van der Vorst JR, Bemelmans MH, Damink OSW, Lassen K, Dejong CH, ORANGE II Study Group (2012) Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS^® programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials 13:54 doi:10.1186/1745-6215-13-54PubMedCentralPubMed

Frutos MD, Abrisqueta J, Lujan J, Abellan I, Parrilla P (2013) Randomized prospective study to compare laparoscopic appendectomy versus umbilical single-incision appendectomy. Ann Surg 257(3):413–418PubMed

Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM, UK MRC CLASICC Trial Group (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25(21):3061–3068PubMed

Marks JM, Phillips MS, Tacchino R, Roberts K, Onders R, DeNoto G, Gecelter G, Rubach E, Rivas H, Islam A, Soper N, Paraskeva P, Rosemurgy A, Ross S, Shah S (2013) Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomy. J Am Coll Surg 216(6):1037–1047PubMed

Mullen JT, Moorman DW, Davenport DL (2009) The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250(1):166–172PubMed

van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218. doi:10.1016/S1470-2045(13)70016-0PubMed

Quante M, Benckert C, Thelen A, Kaisers U, Jonas S (2011) Major abdominal surgery with continued dual antiplatelet therapy. Arch Surg 146(11):1334–1335 (author reply 1335–1336)PubMed

Quenet F, Goéré D, Mehta SS, Roca L, Dumont F, Hessissen M, Saint-Aubert B, Elias D (2011) Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254(2):294–301PubMed

Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D, Pitman MB, Warshaw AL, Lillemoe KD, Fernandez-Del Castillo CF (2013) Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg 258(3):466–475PubMed

Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269PubMed

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414PubMed

Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, Jonas S, Konnopka A, Papsdorf K, Langanke D, Löbner M, Schiefke F, Stolzenburg JU, Weimann A, Wirtz H, König HH, Riedel-Heller S (2013) Co-morbid mental health conditions in cancer patients at working age – prevalence, risk profiles, and care uptake. Psychooncology doi:10.1002/pon.3282

Venkat R, Puhan MA, Schulick RD, Cameron JL, Eckhauser FE, Choti MA, Makary MA, Pawlik TM, Ahuja N, Edil BH, Wolfgang CL (2011) Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg 146(11):1277–1284PubMed

Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh HJ 3rd (2013) 250 robotic pancreatic resections: safety and feasibility. Ann Surg 258(4):554–562PubMed

Bang YJ et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697PubMed

Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247PubMed

Goldman ID, Matherly LH (1985) The cellular pharmacology of methotrexate. Pharmacol Ther 25(1):77–102

Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 256(5517):495–497PubMed

Reilly JJ, Workman P (1993) Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations. Cancer Chemother Pharmacol 32(6):411–418PubMed

Schmoll HJ, Höffken K, Possinger K (1999) Kompendium internistische Onkologie, 3. Aufl. Springer, Heidelberg, S 991–992

Therasse P et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216PubMed

WHO (1976) Handbook for standardized cancer registries

Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, Van der Steen-Banasik E, Trivière N, Stüben G, Puyraveau M, Mercier M (2003) Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Eur J Cancer 39:45–51PubMed

Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMed

Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820PubMedCentralPubMed

Colomer R et al (2007) N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97(5):823–831PubMed

Dennert G, Horneber M (2006) Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 3:CD005037PubMed

Dewey A et al (2007) Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 1:CD004597PubMed

Ezzo JM et al (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2:CD002285PubMed

Horneber MA et al (2008) Mistletoe therapy in oncology. Cochrane Database Syst Rev 2:CD003297 doi:10.1002/14651858.CD003297.pub2PubMed

Kassab S et al (2009) Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2:CD004845 doi:10.1002/14651858.CD004845.pub2PubMed

Feyer P, Ortner P (2009) Supportivtherapie in der Onkologie. Urban & Vogel, München

Fornier M (2010) Denosumab: Second chapter in controlling bone metastases or a new book? J Clin Oncol 35:5127–5131

Moehler M, Al-Batran SE, Andus T et al (2011) German S3-Guideline „Diagnosis and Treatment of Esophagogastric Cancer“. Z Gastroenterol 49:461–531PubMed

Multinational Association of Supportive Care in Cancer. MASCC Guidelines and Assessment Tools. Cliinical Practice Ressources. http://www.mascc.org/guidelines-and-tools

Nekolaichuk CL, Fainsinger RL, Lawlor PG (2005) A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med 19:466–476PubMed

Ripamonti CI, Bandieri E, Roila F (2011) ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 22(Suppl 6):vi69–77PubMed

Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMed

Weimann A, Braga M, Harsanyi L et al (2006) ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 25:224–244PubMed

World Health Organization (2006) Cancer Pain Relief Bd. Volume 19, No. 1. WHO, Geneva

Delbrück H (2003) Krebsnachbetreuung. Springer, Heidelberg

Delbrück H (2007) Rehabilitation and palliation of cancer patients. Springer, Heidelberg

Lynch BM, Cerin E, Owen N, Hawkes AL, Aitken JF (2008) Prospective relationships of physical activity with quality of life among colorectal cancer survivors. J Clin Oncol 26(27):4480–4487PubMed

Pucciani F, Ringressi MN, Redditi S, Masi A, Giani I (2008) Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: Encouraging Results. Dis Colon Rectum 51(10):1552–1558PubMed

Bennett M, Cresswell H (2003) Factors influencing constipation in advanced cancer patients. Palliat Med 17(5):418–422PubMed

Davis MP, Walsh D (2002) Treatment of nausea and vomiting in advanced cancer. Support Care Cancer ####

Klaschnik E (####) Palliativmedizin Praxis, Leitfaden für die palliativmedizinische Alltagsarbeit

Ripamont C, Twycross R, Baines M et al (2001) Clinical-practice recommendations for the management of bowel obstruction with end-stage cancer. Support Care Cancer 9(4):223–233

Schwarzer A, Nauck F, Klaschnik E (2005) Strong opiods and constipation. Schmerz 19(3):214–219PubMed

World Health Organisation (1980) Cancer pain relief. World Health Organization, Genf

Schumacher M, Schulgen G (2008) Methodik klinischer Studien: methodische Grundlagen der Planung, Durchführung und Auswertung, 3. Aufl. Springer, Berlin

Titel: Grundlagen der gastrointestinalen Tumorerkrankungen
verfasst von: Moritz Schmelzle, PD Dr. med.
Sven Jonas, Prof. Dr. med.
Dirk Strumberg, Prof. Dr. med.
Astrid Kaufmann, Dr. med.
Stefan Aretz, Prof. Dr. med.
Uta-Carolin Pietsch, Dr. med.
Udo X. Kaisers, Prof. Dr. med.
Katharina Monz, Dr. med.
Karl-Axel Hartmann, Prof. Dr. med.
Jutta Hübner, PD Dr. med.
Florian Lordick, Prof. Dr. med.
Martin Raida, Dr. med.
Andreas Winter, Dr. med.
Iris Burkholder, Prof. Dr. rer. nat.
Lutz Edler, Dr. rer. nat.
Verlag: Springer Berlin Heidelberg
Buch: Viszeralmedizin
Print ISBN: 978-3-642-14300-7

Electronic ISBN: 978-3-642-14301-4

Copyright-Jahr: 2015
DOI: https://doi.org/10.1007/978-3-642-14301-4_28

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

28. Grundlagen der gastrointestinalen Tumorerkrankungen

Zusammenfassung

Autoren

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Autoren

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Innere Medizin